SAN DIEGO, CA / ACCESS Newswire / December 8, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the launch of IBD Precis ™, a next-generation ...
PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) patients PredictrPK IFX addresses the unmet need of ...
SAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare announced that nine posters on precision-guided care in inflammatory bowel ...
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, presented seven abstracts on precision-guided care in inflammatory ...
Prometheus Biosciences has strong growth potential. Minimal competition ensures demand for its products. RXDX stock is trading at an attractive valuation. RXDX deals in therapeutic antibodies of ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback